Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Brighton, Massachusetts, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention) | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Site, digestive system disorder, digestive system neoplasm, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm, thoracic cancer | Recruiting | Not applicable | 2026-09-16 | NCT05375643 | |
| ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-05-18 | NCT03587740 |